NYLI WMC Value Class C (MMPCX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
19.09
+0.43 (2.30%)
Apr 22, 2025, 4:00 PM EDT
-2.80% (1Y)
| Fund Assets | 1.03B |
| Expense Ratio | 0.71% |
| Min. Investment | $1,000 |
| Turnover | n/a |
| Dividend (ttm) | 1.41 |
| Dividend Yield | 7.38% |
| Dividend Growth | 27.17% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 9, 2024 |
| Previous Close | 18.66 |
| YTD Return | -3.93% |
| 1-Year Return | 3.81% |
| 5-Year Return | 89.97% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | n/a |
| Holdings | 71 |
| Inception Date | Jan 21, 1971 |
About MMPCX
The NYLI WMC Value Class C (MMPCX) seeks to earn income as a secondary objective. MMPCX normally invests at least 65% of its total assets in equity-type securities.
Fund Family MainStay Fds C
Category Large Value
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol MMPCX
Share Class Class C
Index Russell 1000 Value NR
Performance
MMPCX had a total return of 3.81% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.99%.
Top 10 Holdings
24.27% of assets| Name | Symbol | Weight |
|---|---|---|
| JPMorgan Chase & Co. | JPM | 3.98% |
| UnitedHealth Group Incorporated | UNH | 3.35% |
| Johnson & Johnson | JNJ | 3.10% |
| Cisco Systems, Inc. | CSCO | 2.47% |
| Pfizer Inc. | PFE | 1.97% |
| American International Group, Inc. | AIG | 1.97% |
| Elevance Health, Inc. | ELV | 1.93% |
| MetLife, Inc. | MET | 1.85% |
| Gilead Sciences, Inc. | GILD | 1.84% |
| Merck & Co., Inc. | MRK | 1.81% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 9, 2024 | $1.40803 | Dec 9, 2024 |
| Dec 6, 2023 | $1.10722 | Dec 6, 2023 |
| Dec 7, 2022 | $1.41668 | Dec 7, 2022 |
| Dec 2, 2021 | $25.40055 | Dec 2, 2021 |
| Dec 2, 2020 | $1.42314 | Dec 2, 2020 |
| Dec 2, 2019 | $3.20148 | Dec 2, 2019 |